We are live on ! Find out more
AIM

Arcadia Investment Management Portfolio holdings

AUM $584M
1-Year Est. Return 21.44%
This Fund
S&P 500
This Quarter Est. Return
+3.88%
1 Year Est. Return
+21.44%
3 Year Est. Return
+83.48%
5 Year Est. Return
+113.71%
10 Year Est. Return
+434.1%
AUM
$626M
AUM Growth
+$17.3M
Cap. Flow
+$5.69M
Cap. Flow %
0.91%
Top 10 Hldgs %
40.61%
Holding
329
New
75
Increased
63
Reduced
58
Closed
25

Top Buys

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$2.65M
2
MINT icon
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
+$2.28M
3
LLY icon
Eli Lilly
LLY
+$1.58M
4
ADBE icon
Adobe
ADBE
+$1.16M
5
ASML icon
ASML
ASML
+$979K

Top Sells

Rank Stock Value
1
MBLY icon
Mobileye
MBLY
+$1.37M
2
ORCL icon
Oracle
ORCL
+$1.14M
3
TPL icon
Texas Pacific Land
TPL
+$1.1M
4
MDLZ icon
Mondelez International
MDLZ
+$1.07M
5
SBUX icon
Starbucks
SBUX
+$962K

Sector Composition

Rank Sector Weight
1 Technology 39.94%
2 Healthcare 13.11%
3 Consumer Discretionary 9.29%
4 Industrials 8.08%
5 Financials 6.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EMBC icon
301
Embecta
EMBC
$287M
$826 ﹤0.01%
40
– –
ENFN
302
DELISTED
Enfusion, Inc.
ENFN
$804 ﹤0.01%
+78
New +$754
EMQQ icon
303
EMQQ The Emerging Markets Internet & Ecommerce ETF
EMQQ
$275M
$518 ﹤0.01%
15
– –
ACB
304
Aurora Cannabis
ACB
$217M
$17 ﹤0.01%
4
– –
ABCL icon
305
AbCellera Biologics
ABCL
$2.97B
– –
-10,000
Closed -$26K
ALGN icon
306
Align Technology
ALGN
$12.4B
– –
-1,400
Closed -$356K
ATRC icon
307
AtriCure
ATRC
$2.12B
– –
-1,000
Closed -$28K
BEAM icon
308
Beam Therapeutics
BEAM
$2.77B
– –
-4,000
Closed -$98K
CALX icon
309
Calix
CALX
$2.45B
– –
-1,000
Closed -$38.8K
CHTR icon
310
Charter Communications
CHTR
$18.4B
– –
-20
Closed -$6.48K
EDIT icon
311
Editas Medicine
EDIT
$442M
– –
-11,300
Closed -$38.5K
FOLD
312
DELISTED
Amicus Therapeutics
FOLD
– –
-3,000
Closed -$32K
IBRX icon
313
ImmunityBio
IBRX
$8.03B
– –
-1,000
Closed -$3.71K
MCD icon
314
McDonald's
MCD
$193B
– –
-20
Closed -$6.09K
MRSH
315
Marsh
MRSH
$91.2B
– –
-74
Closed -$16.5K
NXPI icon
316
NXP Semiconductors
NXPI
$60.2B
– –
-36
Closed -$8.64K
NXT icon
317
Nextpower Inc
NXT
$15.8B
– –
-2,000
Closed -$74.9K
PYPL icon
318
PayPal
PYPL
$50.4B
– –
-125
Closed -$9.75K
STAA icon
319
STAAR Surgical
STAA
$1.26B
– –
-1,000
Closed -$37.2K
SYM icon
320
Symbotic
SYM
$5.36B
– –
-2,000
Closed -$48.8K
TCMD icon
321
Tactile Systems Technology
TCMD
$546M
– –
-2,000
Closed -$29.2K
UNH icon
322
UnitedHealth
UNH
$368B
– –
-20
Closed -$11.7K
UPST icon
323
Upstart Holdings
UPST
$2.87B
– –
-65
Closed -$2.6K
GTM
324
ZoomInfo Technologies
GTM
$1.24B
– –
-250
Closed -$2.58K
ACHL
325
DELISTED
Achilles Therapeutics
ACHL
– –
-3,000
Closed -$3.06K
10 11 12
13
14

Similar funds

CGIM
Capital Group Investment Management Raffles Quay, Singapore $585M AUM 31.36% 1-Year Est. Return
TAM
Talos Asset Management New York $585M AUM 204.8% 1-Year Est. Return
GIM
Garden Investment Management Greenwich, Connecticut $586M AUM 15.35% 1-Year Est. Return
IIA
IPG Investment Advisors San Diego, California $582M AUM 33.22% 1-Year Est. Return
DLCIG
D.L. Carlson Investment Group Concord, New Hampshire $582M AUM 29.47% 1-Year Est. Return
TCM
Trybe Capital Management Greenwich, Connecticut $581M AUM 112.96% 1-Year Est. Return
FMI
Frec Markets Inc San Francisco, California $587M AUM
PFG
Premier Financial Group Eureka, California $587M AUM 21.88% 1-Year Est. Return

Arcadia Investment Management's Q4 2024 Portfolio in Review

As of Q4 2024, Arcadia Investment Management held 329 positions worth $626M, up 2.8% from $608M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Arcadia Investment Management's Q4 2024 filing shows 75 new, 63 increased, 58 reduced and 25 closed positions. Its largest new stake was Sarepta Therapeutics: 6,935 shares worth $843K. The largest sale was Mobileye, an estimated $1.37M.

By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 38% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Arcadia Investment Management's largest Q4 2024 buy was Sarepta Therapeutics: 6,935 shares worth $843K.
  • Arcadia Investment Management added most to Becton Dickinson in Q4 2024, an estimated $2.65M increase.
  • Arcadia Investment Management's biggest Q4 2024 reduction was Mobileye, cutting an estimated $1.37M.
  • Arcadia Investment Management fully exited Stericycle Inc in Q4 2024, selling an estimated $610K.
  • Arcadia Investment Management's ten largest holdings make up 41% of its $626M portfolio in Q4 2024.
  • Arcadia Investment Management opened 75 new positions and closed 25 in Q4 2024.
  • Arcadia Investment Management's portfolio value rose 2.8% quarter-over-quarter to $626M.

Based on Arcadia Investment Management's 13F filing for Q4 2024, filed 3 Feb 2025.